Rosemina Merchant
Founder bei MEDICENNA THERAPEUTICS CORP.
Vermögen: 7 Mio $ am 31.03.2024
Aktive Positionen von Rosemina Merchant
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MEDICENNA THERAPEUTICS CORP. | Corporate Officer/Principal | 01.10.2011 | - |
Founder | 01.10.2011 | - | |
Director/Board Member | 25.04.2016 | 28.09.2023 | |
Intelligenetics, Inc.
Intelligenetics, Inc. Information Technology ServicesTechnology Services Intelligenetics, Inc. engages in the provision of bioinformatics services. The company is headquartered in Campbell, CA. | General Counsel | 01.01.2001 | - |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | Director/Board Member | 30.10.2011 | - |
Founder | 30.10.2011 | - |
Karriereverlauf von Rosemina Merchant
Ehemalige bekannte Positionen von Rosemina Merchant
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SOPHIRIS BIO | General Counsel | 01.01.2004 | 01.01.2013 |
Intelligene Expressions, Inc. | Chief Operating Officer | 01.01.1992 | 01.01.2002 |
Founder | 01.01.1992 | 01.01.2002 |
Ausbildung von Rosemina Merchant
University of Western Ontario | Graduate Degree |
University of Aston | Undergraduate Degree |
Statistik
International
Kanada | 6 |
Vereinigte Staaten | 2 |
Vereinigtes Königreich | 2 |
Operativ
Founder | 3 |
General Counsel | 2 |
Director/Board Member | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MEDICENNA THERAPEUTICS CORP. | Health Technology |
Private Unternehmen | 4 |
---|---|
Sophiris Bio, Inc.
Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA. | Health Technology |
Intelligenetics, Inc.
Intelligenetics, Inc. Information Technology ServicesTechnology Services Intelligenetics, Inc. engages in the provision of bioinformatics services. The company is headquartered in Campbell, CA. | Technology Services |
Intelligene Expressions, Inc. | |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | Health Technology |
- Börse
- Insiders
- Rosemina Merchant
- Erfahrung